Meltzer, Sebastian http://orcid.org/0000-0001-6640-3927
Negård, Anne
Bakke, Kine M.
Hamre, Hanne M.
Kersten, Christian
Hofsli, Eva
Guren, Marianne G.
Sorbye, Halfdan
Flatmark, Kjersti
Ree, Anne Hansen http://orcid.org/0000-0002-8264-3223
Funding for this research was provided by:
Kreftforeningen (215613)
Ministry of Health and Care Services | Helse Sør-Øst RHF (18054)
Bristol-Myers Squibb
Article History
Received: 28 May 2022
Revised: 21 September 2022
Accepted: 27 September 2022
First Online: 13 October 2022
Competing interests
: AHR received, on behalf of Akershus University Hospital, a research grant from Bristol Myers-Squibb to conduct the METIMMOX trial. The authors declare no other potential conflicts of interest.
: The study was performed in accordance with the Declaration of Helsinki and approved by the South-Eastern Regional Health Ethics Committee in Norway (ref. 2017/1850). Written informed consent was required for participation.
: Not applicable.